Marshall Wace’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Marshall Wace’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,355	Closed	-$31K	–	4219
2021 Q4	$31K	Sell	2,355 -13,364	-85%	-$221K	﹤0.01%	3648
2021 Q3	$361K	Buy	+15,719	New	+$468K	﹤0.01%	2564
2020 Q3	–	Sell	-6,642	Closed	-$399K	–	2009
2020 Q2	$399K	Buy	+6,642	New	+$609K	﹤0.01%	1260
2020 Q1	–	Sell	-13,883	Closed	-$1.91M	–	2159
2019 Q4	$1.91M	Buy	13,883 +11,071	+394%	+$1.35M	0.01%	825
2019 Q3	$334K	Buy	2,812 +294	+12%	+$41K	﹤0.01%	1181
2019 Q2	$352K	Buy	+2,518	New	+$442K	﹤0.01%	1151

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Marshall Wace's ORTX Position: Q1 2022 in Review

Marshall Wace sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2022, closing a stake of 2,355 shares — an estimated $31K sold.

Marshall Wace first reported a position in ORTX in Q2 2019 and held it in 6 quarters. The position peaked at $1.91M in Q4 2019. 61 funds tracked by Wall St. Rank hold ORTX as of Q1 2022.

Marshall Wace reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Marshall Wace sold 2,355 Orchard Therapeutics plc American Depositary Shares shares in Q1 2022, an estimated $31K.
Marshall Wace first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and held it in 6 quarters.
Marshall Wace's Orchard Therapeutics plc American Depositary Shares position peaked at $1.91M in Q4 2019.
61 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2022.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.